Vector Laboratories

Vector Laboratories, Inc. specializes in the research, development, and manufacturing of labeling and detection solutions for the scientific community. Established in 1976 and based in Burlingame, California, the company offers a diverse range of products, including lectin reagents, VECTASTAIN ABC kits for tissue staining, polymer detection reagents, primary and secondary antibodies, enzyme substrates, and biotin-(strept)avidin systems. These products are essential in various applications such as immunohistochemistry, immunofluorescence, and molecular biology. Vector Laboratories is recognized for its innovative developments, including the ImmPRESS polymer detection systems and the VECTASHIELD anti-fade mounting mediums. The company also provides accessory items like antigen unmasking solutions and blocking kits to enhance research accuracy. With subsidiaries in the United Kingdom and Canada, Vector Laboratories distributes its products internationally, serving researchers in hospitals, academic institutions, and life science companies. Its significant presence in scientific literature underscores the quality and reliability of its offerings.

Lisa Sellers Ph.D

CEO

4 past transactions

Quanta BioDesign

Acquisition in 2023
Quanta BioDesign was founded for the purpose of developing and commercializing an extensive line of products for companies involved in drug discovery and diagnostic development programs.

Click Chemistry Tools

Acquisition in 2023
Click Chemistry Tools is connected to the development and expansion of a ligation product range. Their research unit is made up of a team of scientists that work together to develop cross-linking and labeling reagents based on the recent research. Many research and academic institutes, both domestically and internationally, employ their products to develop drug discoveries, therapeutic approaches, and diagnostic techniques. The team of scientists provides timely technical support to meet any of their client's demands, and also precise recommendations for the effective use of various goods. They also offer ligation product manufacturing to fulfill the physical, chemical, and morphological requirements in a range of applications.

Fluoroprobes

Acquisition in 2023
Fluoroprobes specializes in the manufacturing of high-purity fluorescent dyes, catering to the diagnostics, peptide, and oligonucleotide industries. Leveraging its expertise in fluorescent probes and dyes, the company produces compounds that match the quality and reliability of those offered by larger competitors, but at significantly lower costs. Fluoroprobes is committed to ensuring the quality and reproducibility of its products, making it a competitive player in the market for fluorescent compounds.

Celerus Diagnostics

Series B in 2006
Founded in 2004 in Santa Barbara, California, Celerus Diagnostics develops innovative technological solutions that enhance the diagnostic capabilities of anatomic pathology laboratories, provide clinicians with rapid, reliable, actionable diagnostic information, and advance patient care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.